BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6548939)

  • 21. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
    Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
    Säwe J
    Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability of ibuprofen from oral and suppository preparations in rats.
    Kaka JS; Tekle A
    Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):171-82. PubMed ID: 1604043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
    Kharasch ED; Hoffer C; Whittington D; Sheffels P
    Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rectal absorption and disposition of secobarbital in epileptic children.
    Levine HL; Cohen ME; Duffner PK; Lacey DJ; Karpynec R; Shen DD
    Pediatr Pharmacol (New York); 1982; 2(1):33-8. PubMed ID: 7110754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, randomized, crossover comparison between single-dose and double-dose immediate-release oral morphine at bedtime in cancer patients.
    Dale O; Piribauer M; Kaasa S; Moksnes K; Knobel H; Klepstad P
    J Pain Symptom Manage; 2009 Jan; 37(1):68-76. PubMed ID: 18504090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further development of a morphine hydrogel suppository.
    Cole L; Hanning CD; Robertson S; Quinn K
    Br J Clin Pharmacol; 1990 Dec; 30(6):781-6. PubMed ID: 2288824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential cost-avoidance with oral extended-release morphine sulfate tablets versus morphine sulfate solution.
    Goughnour BR; Arkinstall WW
    Am J Hosp Pharm; 1991 Jan; 48(1):101-4. PubMed ID: 2000864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative bioavailability of a morphine suppository given rectally and in a colostomy.
    Højsted J; Rubeck-Petersen K; Rask H; Bigler D; Broen Christensen C
    Eur J Clin Pharmacol; 1990; 39(1):49-50. PubMed ID: 2276388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absorption of valproic acid suppositories in human volunteers.
    Holmes GB; Rosenfeld WE; Graves NM; Remmel RP; Carlson GH; Kriel RD
    Arch Neurol; 1989 Aug; 46(8):906-9. PubMed ID: 2502974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel patch for transdermal administration of morphine.
    Inui N; Kato T; Uchida S; Chida K; Takeuchi K; Kimura T; Watanabe H
    J Pain Symptom Manage; 2012 Oct; 44(4):479-85. PubMed ID: 22727949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration.
    Ishizaki T; Sasaki T; Suganuma T; Horai Y; Chiba K; Watanabe M; Asuke W; Hoshi H
    Eur J Clin Pharmacol; 1980 Nov; 18(5):407-14. PubMed ID: 7439263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of rectal cisapride on morphine-induced gastric stasis.
    Kluger MT; Plummer JL; Owen H
    Anaesth Intensive Care; 1991 Aug; 19(3):346-50. PubMed ID: 1767901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the hydrophilicity of suppository bases on rectal absorption of carprofen, a lipophilic nonsteroidal anti-inflammatory drug.
    Schmitt M; Guentert TW
    J Pharm Sci; 1990 Apr; 79(4):359-63. PubMed ID: 2352151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and bioavailability of theophylline following enema and suppository administration in man.
    Cole ML; Kunka RL
    Biopharm Drug Dispos; 1984; 5(3):229-40. PubMed ID: 6548392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma concentrations of flunitrazepam (Rohypnol) following oral and sublingual administration.
    Hüttel MS; Bang U; Flachs H
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):221-3. PubMed ID: 3710635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability of suppository acetaminophen in healthy and hospitalized ill dogs.
    Sikina ER; Bach JF; Lin Z; Gehring R; KuKanich B
    J Vet Pharmacol Ther; 2018 Oct; 41(5):652-658. PubMed ID: 29756216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biopharmaceutical evaluation of ketoprofen following intravenous, oral, and rectal administration in dogs.
    Schmitt M; Guentert TW
    J Pharm Sci; 1990 Jul; 79(7):614-6. PubMed ID: 2398469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceutical evaluation of hollow type suppositories. IV. Improvement of bioavailability of propranolol in rabbits after rectal administration.
    Watanabe Y; Matsumoto Y; Baba K; Matsumoto M
    J Pharmacobiodyn; 1986 Jun; 9(6):526-31. PubMed ID: 3761140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug administration through the rectum: reliability, tolerance].
    Cheymol G
    Ann Gastroenterol Hepatol (Paris); 1987; 23(4):195-200. PubMed ID: 3662416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.